Back to dashboard
CommercialCoverageMedium impact

Cervical Cancer Screening Technologies with Pap and HPV

Blue Cross & Blue Shield of Mississippi·MS · OB-GYN, Family Medicine, Internal Medicine·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

BCBS Mississippi updated their cervical cancer screening policy covering Pap smears and HPV testing technologies. The policy defines what cervical screening methods are considered medically necessary versus investigational, including monolayer slide preparation systems, automated screening systems, and HPV testing protocols.

Action Required

Action needed
Immediately: Review current cervical cancer screening billing practices to ensure compliance with BCBS MS coverage criteria. Verify that HPV testing is only billed when there is documented abnormal Pap smear (ASC-US or other abnormalities) in the medical record. Ensure automated screening systems are not being used for high-risk patients as this is considered investigational. Update staff on medically necessary versus investigational screening technologies.